期刊
NEUROTHERAPEUTICS
卷 13, 期 1, 页码 96-107出版社
SPRINGER
DOI: 10.1007/s13311-015-0401-7
关键词
Immune-mediated neuropathies; Guillain-Barre syndrome; Chronic inflammatory demyelinating polyradiculoneuropathy; Multifocal motor neuropathy; IgManti-myelin-associated-glycoprotein neuropathy; Immunomodulatory treatments
资金
- Biogen-Idec
- Baxter
- CSL-Behring
- Kedrion
- LFB
- Novartis
- Octapharma
Immunotherapy has been investigated in a small subset of peripheral neuropathies, including an acute one, Guillain-Barre syndrome, and 3 chronic forms: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and neuropathy associated with IgM anti-myelin-associated glycoprotein. Several experimental studies and clinical data are strongly suggestive of an immune-mediated pathogenesis. Either cell-mediated mechanisms or antibody responses to Schwann cell, compact myelin, or nodal antigens are considered to act together in an aberrant immune response to cause damage to peripheral nerves. Immunomodulatory treatments used in these neuropathies aim to act at various steps of this pathogenic process. However, there are many phenotypic variants and, consequently, there is a significant difference in the response to immunotherapy between these neuropathies, as well as a need to improve our knowledge and long-term management of chronic forms.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据